Connor, Clark & Lunn Investment Management (CC&L)’s Arena Pharmaceuticals Inc ARNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,579
| Closed | -$240K | – | 1294 |
|
|
2021
Q4 | $240K | Sell |
2,579
-13,781
| -84% | -$1.28M | ﹤0.01% | 936 |
|
|
2021
Q3 | $974K | Buy |
+16,360
| New | +$974K | 0.01% | 653 |
|
|
2019
Q4 | – | Sell |
-15,875
| Closed | -$727K | – | 1143 |
|
|
2019
Q3 | $727K | Buy |
15,875
+5,025
| +46% | +$230K | 0.01% | 603 |
|
|
2019
Q2 | $636K | Buy |
+10,850
| New | +$636K | ﹤0.01% | 673 |
|
|
2017
Q3 | – | Sell |
-14,691
| Closed | -$248K | – | 954 |
|
|
2017
Q2 | $248K | Buy |
14,691
+1,951
| +15% | +$32.9K | ﹤0.01% | 708 |
|
|
2017
Q1 | $186K | Buy |
12,740
+110
| +0.9% | +$1.61K | ﹤0.01% | 809 |
|
|
2016
Q4 | $179K | Sell |
12,630
-1,550
| -11% | -$22K | ﹤0.01% | 801 |
|
|
2016
Q3 | $248K | Sell |
14,180
-1,080
| -7% | -$18.9K | ﹤0.01% | 706 |
|
|
2016
Q2 | $261K | Hold |
15,260
| – | – | ﹤0.01% | 702 |
|
|
2016
Q1 | $301K | Sell |
15,260
-4,500
| -23% | -$88.8K | ﹤0.01% | 651 |
|
|
2015
Q4 | $375K | Buy |
19,760
+3,360
| +20% | +$63.8K | ﹤0.01% | 596 |
|
|
2015
Q3 | $313K | Buy |
+16,400
| New | +$313K | ﹤0.01% | 590 |
|